Innate Pharma Stock
Innate Pharma Stock
The Innate Pharma stock is trending slightly upwards today, with an increase of €0.002 (0.140%) compared to yesterday's price.
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 0.140% | - | -1.731% | -21.656% | -3.529% | -52.994% | -61.158% |
| Adocia | -4.760% | -4.630% | 2.658% | 15.084% | -6.364% | 84.478% | -43.094% |
| Valneva SE | -1.720% | 6.512% | -2.134% | 13.441% | 11.877% | -30.294% | -68.413% |
| Cellectis Nom. | 7.590% | 8.046% | -9.241% | 114.472% | -21.667% | 42.919% | -85.442% |
